Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| CLC-H5245 | Human | Human CLEC4C / BDCA2 Protein, His Tag |  |
|
|
| CLC-C52H4 | Cynomolgus | Cynomolgus CLEC4C / BDCA2 Protein, His Tag (MALS verified) |  |
|
|
| CLC-H5254 | Human | Human CLEC4C / BDCA2 Protein, Fc Tag |  |
|
Immobilized Cynomolgus CLEC4C, His Tag (Cat. No. CLC-C52H4) at 1 μg/mL (100 μL/well) can bind Litifilimab with a linear range of 0.06-2 ng/mL (QC tested).
The purity of Cynomolgus CLEC4C, His Tag (Cat. No. CLC-C52H4) is more than 90% and the molecular weight of this protein is around 59-80 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Litifilimab | BIIB-059 | Phase 3 Clinical | Biogen Inc | Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic | Details |
| SSGJ-626 | SSGJ-626; 626 | Phase 1 Clinical | Sunshine GuoJian Pharmaceutical (Shanghai) Co Ltd | Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic | Details |
| Recombinant anti-BDCA2 humanized monoclonal antibody (Sansheng Guojian) | Phase 1 Clinical | Sunshine GuoJian Pharmaceutical (Shanghai) Co Ltd | Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic | Details | |
| DB-2304 | DB-2304 | Phase 1 Clinical | Duality Biologics (Suzhou) Co Ltd | Autoimmune Diseases | Details |
This web search service is supported by Google Inc.
A-Z
